arrow
Y

Yoshitaka Narita

National Cancer Center Hospital
H指数:56
被引数:1.0万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

SNP rs2853669 potentially elevates the risk of glioblastoma development and leads to worse prognosis when in cis with mutant TERT promoter in a Japanese cohort

SNP rs2853669在顺式与突变TERT启动子共存时,可能增加日本队列中胶质母细胞瘤的发病风险并导致更差的预后

2026-09-280
OAAI
Role of antiseizure medication in postoperative late seizure and survival among patients with newly diagnosed glioblastoma: a multicenter retrospective study

新诊断胶质母细胞瘤患者术后晚期癫痫和生存中抗癫痫药物的作用:一项多中心回顾性研究

2026-08-070
OA
Clonal analysis of a case with fluid overload-associated large B-cell lymphoma evolving from primary large B-cell lymphoma of the central nervous system

一例液体超负荷相关的大B细胞淋巴瘤(由中枢神经系统原发性大B细胞淋巴瘤演变而来)的克隆分析

2026-03-110
OAAI
Molecular and clinical features of a Japanese medulloblastoma cohort: Subgroup-specific prognostic stratification using economical/accessible diagnostic methods

日本髓母细胞瘤队列的分子与临床特征:采用经济/便捷的诊断方法进行亚组特异性预后分层

2026-03-110
OAAI
Local therapy with hypoxia-targeting radiopharmaceutical [64Cu]Cu-ATSM in high-grade glioma patient-derived xenograft models

使用缺氧靶向放射性药物[64Cu]Cu-ATSM进行局部治疗,在高级别胶质瘤患者来源的异种移植模型中。

2025-12-070
PRE
Phase II study of safusidenib erbumine in patients with chemotherapy- and radiotherapy-naïve isocitrate dehydrogenase 1-mutated WHO grade 2 gliomas

II期研究:safusidenib erbumine在化疗和放疗初治的异柠檬酸脱氢酶1突变型WHO II级胶质瘤患者中的应用

2025-11-080
OAAI
Chromosome 15q15 Deletion Drives Brain Metastasis in Non-Small Cell Lung Cancer

染色体15q15缺失驱动非小细胞肺癌脑转移

2025-11-070
PRE
PATIENT BACKGROUNDS ASSOCIATED WITH THE PROLONGED EFFECTIVENESS OF TIRABRUTINIB IN PATIENTS WITH RELAPSED OR REFRACTORY PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA: RESULTS FROM THE ROSETTA STUDY

与替拉 Brutinib 持续有效性相关的患者背景:复发或难治性原发性中枢神经系统淋巴瘤患者的 ROSETTA 研究结果

2025-11-010
OAAI
A PHASE 2 STUDY OF PEMIGATINIB FOR PRE-TREATED GLIOBLASTOMA OR OTHER GLIOMAS WITH ACTIVATING FGFR1-3 ALTERATIONS: FINAL RESULTS FROM FIGHT-209

一项关于佩米加替尼治疗经治胶质母细胞瘤或其他携带激活性FGFR1-3变异的胶质瘤的II期研究:FIGHT-209的最终结果

2025-10-010
OAAI
Dummy run study for outlining and plan quality of intensity-modulated radiotherapy in elderly patients with newly diagnosed glioblastoma: The Japan clinical oncology group study JCOG1910 (AgedGlio-PIII)
2025-03-090
OAAI